Ginkgo Bioworks Holdings (DNA) Retained Earnings (2021 - 2026)

Ginkgo Bioworks Holdings has reported Retained Earnings for 6 years, with the latest figure at -$6.2 billion in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings fell 733183.18% year-over-year to -$6.2 billion; the trailing twelve-month figure through Mar 2026 stood at -$6.2 billion (down 733183.18% YoY), and the FY2025 full-year result was -$6.2 billion, down 340449.28% from the prior year.
• Retained Earnings for Q1 2026 stood at -$6.2 billion, down from -$6.2 billion in the prior quarter.
• The five-year high for Retained Earnings was $5.2 million in Q1 2022, with the low at -$6.2 billion in Q1 2026.
• Historically, Retained Earnings has averaged -$1.6 billion across 5 years, with a median of -$1.6 million in 2024.
• Annual changes were most pronounced in 2025 — Retained Earnings surged 658.94% — and 2026, when it sank 733183.18%.
• Ginkgo Bioworks Holdings' Retained Earnings stood at -$4.4 billion in 2022, then soared by 100.03% to $1.5 million in 2023, then plunged by 221.7% to -$1.8 million in 2024, then tumbled by 340449.28% to -$6.2 billion in 2025, then slipped by 1.34% to -$6.2 billion in 2026.
• The last three Retained Earnings figures came in at -$6.2 billion (Q1 2026), -$6.2 billion (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.